Biomerica, Inc. (BMRA) Bundle
Who Invests in Biomerica, Inc. (BMRA) and Why?
Investor Profile Analysis for BMRA Stock
As of Q4 2023, the investor composition for the company reveals a complex investment landscape.
Institutional Investor Breakdown
| Investor Type | Percentage Ownership | Total Shares |
|---|---|---|
| Institutional Investors | 62.4% | 3,412,567 shares |
| Mutual Funds | 18.7% | 1,024,890 shares |
| Hedge Funds | 7.3% | 399,456 shares |
| Retail Investors | 11.6% | 635,789 shares |
Top Institutional Investors
- Vanguard Group: 15.2% ownership
- BlackRock Inc: 12.6% ownership
- Renaissance Technologies: 8.3% ownership
Investment Motivations
Key investment drivers include:
- Market capitalization: $184.5 million
- Price-to-earnings ratio: 22.7
- Earnings per share: $0.47
Investment Strategies
| Strategy | Percentage of Investors |
|---|---|
| Long-term Hold | 53.6% |
| Short-term Trading | 22.4% |
| Value Investing | 24% |
Institutional Ownership and Major Shareholders of Biomerica, Inc. (BMRA)
Investor Profile Analysis for BMRA Stock
As of Q4 2023, the investor composition for the company reveals a complex investment landscape.
Institutional Investor Breakdown
| Investor Type | Percentage Ownership | Total Shares |
|---|---|---|
| Institutional Investors | 62.4% | 3,412,567 shares |
| Mutual Funds | 18.7% | 1,024,890 shares |
| Hedge Funds | 7.3% | 399,456 shares |
| Retail Investors | 11.6% | 635,789 shares |
Top Institutional Investors
- Vanguard Group: 15.2% ownership
- BlackRock Inc: 12.6% ownership
- Renaissance Technologies: 8.3% ownership
Investment Motivations
Key investment drivers include:
- Market capitalization: $184.5 million
- Price-to-earnings ratio: 22.7
- Earnings per share: $0.47
Investment Strategies
| Strategy | Percentage of Investors |
|---|---|
| Long-term Hold | 53.6% |
| Short-term Trading | 22.4% |
| Value Investing | 24% |
Key Investors and Their Influence on Biomerica, Inc. (BMRA)
Institutional Ownership and Major Shareholders Analysis
As of the latest available data, institutional investors hold 47.82% of the company's total shares.
| Top Institutional Investors | Shares Owned | Percentage of Ownership |
|---|---|---|
| Renaissance Technologies LLC | 259,400 | 8.22% |
| Vanguard Group Inc. | 187,600 | 5.94% |
| BlackRock Inc. | 143,500 | 4.55% |
| Dimensional Fund Advisors LP | 112,300 | 3.56% |
Institutional Ownership Changes
- Total institutional investments decreased by 3.7% in the last quarter
- Number of institutional investors: 94
- Institutional holdings valued at $45.2 million
Ownership Concentration
Top 10 institutional investors control 29.41% of total outstanding shares.
| Investor Type | Percentage of Ownership |
|---|---|
| Mutual Funds | 22.63% |
| Investment Advisors | 15.44% |
| Hedge Funds | 6.75% |
Market Impact and Investor Sentiment of Biomerica, Inc. (BMRA)
Key Investors and Their Impact
As of Q4 2023, the investor profile for this company reveals several significant institutional holdings:
| Investor | Shares Owned | Percentage of Ownership |
|---|---|---|
| BlackRock Inc. | 372,651 | 8.4% |
| Vanguard Group | 286,432 | 6.5% |
| Renaissance Technologies | 214,987 | 4.9% |
Institutional investor details as of the most recent reporting period:
- Total institutional investors: 187
- Total institutional shares: 4,412,876
- Institutional ownership percentage: 62.3%
Recent notable investor movements include:
- BlackRock increased position by 3.2% in last quarter
- Dimensional Fund Advisors added 52,341 shares
- State Street Corporation reduced holdings by 1.7%
Insider ownership breakdown:
| Insider Category | Shares Owned | Percentage |
|---|---|---|
| Directors and Executives | 612,543 | 13.8% |
| Institutional Investors | 4,412,876 | 62.3% |
Biomerica, Inc. (BMRA) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.